ABSTRACT
BACKGROUND: Diarrhea can be caused by pathogenic microorganisms and chemicals. In view of this, Byrsocarpus coccineus Schum and Thonn (Connaraceae) was used to treat diarrhea induced by castor oil or bacteria in Wistar albino rats. METHODS: Qualitative and quantitative analyses of an aqueous root back extract of B. coccineus were made and the acute toxicity, antidiarrhea properties, and in vitro and in vivo antimicrobial activities of the extract were investigated in rats. RESULTS: The phytochemical analysis of the root bark extract revealed the presence of flavonoids, alkaloid, saponins, tannins, and phenols. The quantitative analysis showed that saponins formed 10.6% of the extract, tannins 7.6%, flavonoids 6.2%, phenol 5.8% and alkaloids 4.4%. A dose limit of 5000 mg/kg was safe to use in the rats. At a dose of 100 mg/kg, the extract decreased distance travelled by activated charcoal in the gastrointestinal tract, frequency of defecation, and number of unformed faeces caused by castor oil-induced diarrhea, and led to 74.96% inhibition of the diarrhea effects. Escherichia coli and Salmonella pullorum were susceptible to higher concentrations of the extract with a minimum inhibitory concentration of 0.3125 mg/mL. E. coli-infected rats showed depression, weight loss, anorexia, diarrhea, and weakness, which was ameliorated by the extract on day 2 post treatment. Observed congestion, cellular infiltration and necrosis of the liver, intestine and kidney following infection were improved by the extract. CONCLUSION: B. coccineus extract can be used in the treatment of anaemia, and castor oil- and E. coli-induced diarrhea in rats.
ABSTRACT
The effects of vitamin C administration at varying time intervals on rectal temperature, respiratory rates, heart rates and sleeping time following xylazine anaesthesia was evaluated in rabbits. A total of 36 rabbits placed in six groups (A-F) with 6 animals per group each were used. Groups A and B were used as controls for vitamin C (120 mg/kg, oral) and xylazine (4 mg/kg, intramuscular) treatments, respectively, while groups C-F received vitamin C at four intervals prior to xylazine anaesthesia. The result of the study showed that vitamin C pre-medication prior to xylazine anaesthesia induced depression in respiratory and heart rates and a slight increase in rectal temperature. It also significantly increased sleeping time in rabbits (p<0.05). The lengthiest duration of sleep was observed among rabbits that received vitamin C 60 min prior to xylazine anaesthesia. Vitamin C administration 10 min prior to xylazine anaesthesia in rabbits induced a sleeping time three times the value compared to those animals that had received xylazine anaesthesia alone. However, the study did not observe a significant difference (p>0.05) in temperature between groups either before or after xylazine administration. It was concluded that vitamin C alters the clinical parameters as well as the sleeping time in rabbits under xylazine anaesthesia.
